Literature DB >> 6980077

Piroxicam, aspirin, and gastrointestinal blood loss.

J R Bianchine, R R Procter, F B Thomas.   

Abstract

A study to compare the effects of three piroxicam regimens and aspirin on fecal blood loss (FBL) was conducted among 39 healthy men. Fourteen of the subjects also underwent prestudy and poststudy gastroscopy. There was an increase in FBL after aspirin, 972 mg 4 times a day, whereas piroxicam, 20 mg once a day, 5 mg four times a day, and 20 mg four times a day induced no observable increase in fecal blood loss. There was gastroscopic evidence of irritation in the aspirin group, but not in any of the piroxicam groups.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6980077     DOI: 10.1038/clpt.1982.155

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  3 in total

1.  Lornoxicam, indomethacin and placebo: comparison of effects on faecal blood loss and upper gastrointestinal endoscopic appearances in healthy men.

Authors:  S J Warrington; N M Debbas; M Farthing; M Horton; A Johnston; A Thillainayagam; P Turner; H Ferber
Journal:  Postgrad Med J       Date:  1990-08       Impact factor: 2.401

Review 2.  Piroxicam. A reappraisal of its pharmacology and therapeutic efficacy.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

Review 3.  Etodolac, a new nonsteroidal anti-inflammatory drug: gastrointestinal microbleeding and endoscopic studies.

Authors:  F L Lanza; J D Arnold
Journal:  Clin Rheumatol       Date:  1989-03       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.